positron emission tomography (PET) imaging

December 3, 2020December 3, 2020

FDA Approves First PSMA-targeted PET Imaging Agent for Prostate Cancer

News

The U.S. Food and Drug Administration (FDA) has approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) as a positron emission tomography or PET imaging agent for men with prostate cancer. The ... Read more

April 18, 2017

CTT to Present Data on Prostate Cancer Therapy Candidates at Upcoming Conferences

News

The most recent performance data on Cancer Targeted Technology’s (CTT) leading drugs, CTT1057 and CTT1403, in prostate cancer clinical and preclinical studies will be presented at several scientific and business ... Read more